CA 15-3 may be useful for monitoring patients with metastic breast cancer and certain ovarian cancers. The CA 15-3 values from sequential samples have a high correlation with the clinical course in most patients with metastatic breast cancer.
Reported (Analytical Time)
The CPT codes provided are based on AMA guidelines and are for informational purposes only.
CPT coding is the sole responsibility of the billing party.
Please direct any questions regarding coding to the payer being billed.
Transport Temperature: Room Temperature Reject Criteria: Gross hemolysis; Grossly lipemic Methodology: Immunoassay Assay Category: FDA Approved/Cleared